215 related articles for article (PubMed ID: 31914836)
21. Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.
Sawatzky E; Wehle S; Kling B; Wendrich J; Bringmann G; Sotriffer CA; Heilmann J; Decker M
J Med Chem; 2016 Mar; 59(5):2067-82. PubMed ID: 26886849
[TBL] [Abstract][Full Text] [Related]
22. Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-Aβ Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation.
Jiang CS; Ge YX; Cheng ZQ; Wang YY; Tao HR; Zhu K; Zhang H
Molecules; 2019 Jul; 24(14):. PubMed ID: 31311169
[TBL] [Abstract][Full Text] [Related]
23. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
[TBL] [Abstract][Full Text] [Related]
25. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
[TBL] [Abstract][Full Text] [Related]
27. Novel amides of 1,1-bis-(carboxymethylthio)-1-arylethanes: Synthesis, characterization, acetylcholinesterase, butyrylcholinesterase, and carbonic anhydrase inhibitory properties.
Taslimi P; Osmanova S; Caglayan C; Turkan F; Sardarova S; Farzaliyev V; Sujayev A; Sadeghian N; Gulçin İ
J Biochem Mol Toxicol; 2018 Sep; 32(9):e22191. PubMed ID: 29992664
[TBL] [Abstract][Full Text] [Related]
28. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors.
Ma W; Bi J; Zhao C; Gao Y; Zhang G
Carbohydr Res; 2020 May; 491():107977. PubMed ID: 32169593
[TBL] [Abstract][Full Text] [Related]
31. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors.
Ghobadian R; Nadri H; Moradi A; Bukhari SNA; Mahdavi M; Asadi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Sharifzadeh M; Amini M
Bioorg Med Chem; 2018 Sep; 26(17):4952-4962. PubMed ID: 30190181
[TBL] [Abstract][Full Text] [Related]
33. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
Atatreh N; Al Rawashdah S; Al Neyadi SS; Abuhamdah SM; Ghattas MA
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1373-1379. PubMed ID: 31347933
[TBL] [Abstract][Full Text] [Related]
34. N-methylated diazabicyclo[3.2.2]nonane substituted triterpenoic acids are excellent, hyperbolic and selective inhibitors for butyrylcholinesterase.
Heise N; Friedrich S; Temml V; Schuster D; Siewert B; Csuk R
Eur J Med Chem; 2022 Jan; 227():113947. PubMed ID: 34731766
[TBL] [Abstract][Full Text] [Related]
35. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
[TBL] [Abstract][Full Text] [Related]
36. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
37. 2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling.
Delogu GL; Matos MJ; Fanti M; Era B; Medda R; Pieroni E; Fais A; Kumar A; Pintus F
Bioorg Med Chem Lett; 2016 May; 26(9):2308-13. PubMed ID: 26995529
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors.
Baumann K; Kordić L; Močibob M; Šinko G; Tomić S
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382668
[TBL] [Abstract][Full Text] [Related]
39. Triterpene-Based Carboxamides Act as Good Inhibitors of Butyrylcholinesterase.
Loesche A; Kahnt M; Serbian I; Brandt W; Csuk R
Molecules; 2019 Mar; 24(5):. PubMed ID: 30866589
[TBL] [Abstract][Full Text] [Related]
40. Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations.
Zhou Y; Lu X; Yang H; Chen Y; Wang F; Li J; Tang Z; Cheng X; Yang Y; Xu L; Xia Q
Molecules; 2019 Nov; 24(23):. PubMed ID: 31757047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
